cefmetazole has been researched along with cefotiam in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (40.91) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
| Fujimoto, M; Sakai, K; Ueda, T | 1 |
| Hiraoka, T; Nakakuma, K; Ogata, K; Ootsuka, K; Tashiro, S | 1 |
| Kojo, H; Nishida, M; Shigi, Y | 1 |
| Brogard, JM; Comte, F | 1 |
| Neu, HC | 1 |
| Deguchi, K; Fujimaki, Y; Kawamura, S; Ohsawa, H; Sugita, R | 1 |
| Fujimura, H; Nozaki, M; Okada, K; Tsurumi, K; Yanagihara, M | 1 |
| Fujimoto, S; Furuta, I; Harikane, O; Hiromatsu, K; Iimori, M; Kamiki, T; Kodama, J; Kotera, K; Maejima, K; Masutani, T; Matsunaga, K; Miwatani, T; Nishimura, T; Nukina, M; Shimizu, Y; Tabuki, K; Takahashi, M; Takashima, E; Takashima, T; Takeda, Y; Tanaka, M; Yabuuchi, E; Yamanaka, K; Yoshizaki, E | 1 |
| Matsuo, K; Uete, T | 4 |
| Abe, M; Imaoka, Y; Kamiyama, Y; Kunii, Y; Masamune, R; Momono, S; Oouchi, K; Toyoda, T; Toyoshima, T; Watanabe, I | 1 |
| Goto, K; Nishida, M; Oda, M; Saitoh, H; Takada, M | 1 |
| Harada, M; Nagata, M; Nakamura, K; Takeuchi, M; Watanabe, A | 1 |
| Araake, M; Hara, T; Tsuruoka, T; Watabe, H | 1 |
| Abe, T; Sato, Y; Sei, M | 1 |
| Fukushima, Y; Hiraoka, N; Morimoto, T; Morita, S; Nishisho, I; Nomura, T; Shibata, N | 1 |
| Mikamo, H; Shinagawa, N; Takeyama, H; Taniguchi, M; Yokoyama, T; Yura, J | 1 |
| Fang, Y; Fu, Z; Guan, Y; Jiang, J; Long, C; Sun, P; Wan, C; Wu, C; Zhao, J | 1 |
| Ando, R; Asaoka, M; Etani, T; Hori, K; Iida, K; Kawai, N; Kondo, S; Nagai, T; Naiki, T; Nakamura, A; Noda, Y; Nozaki, S; Shimizu, N; Wachino, C; Yanagita, T; Yasui, T | 1 |
2 review(s) available for cefmetazole and cefotiam
| Article | Year |
|---|---|
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
1 trial(s) available for cefmetazole and cefotiam
| Article | Year |
|---|---|
[Combination use of second generation cephem and isepamicin for the treatment of post-surgical infection of the lower digestive tract].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefmetazole; Cefotiam; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Female; Gentamicins; Humans; Intestinal Diseases; Intestines; Male; Middle Aged; Peritonitis; Postoperative Complications; Surgical Wound Infection | 1997 |
19 other study(ies) available for cefmetazole and cefotiam
| Article | Year |
|---|---|
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Studies of cefotaxime serum concentrations during surgery under general anaesthesia and its passage to the wound fluid after surgery for breast cancer.
Topics: Anesthesia, General; Breast; Breast Neoplasms; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Ceftizoxime; Ceftriaxone; Cephamycins; Exudates and Transudates; Female; Humans; Mastectomy; Premedication | 1985 |
Hepatic hematoma after blunt trauma--a case of nonoperative management to prevent liver abscess formation.
Topics: Adolescent; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cephalothin; Cephamycins; Dibekacin; Hematoma; Humans; Injections, Intra-Arterial; Liver; Liver Abscess; Liver Diseases; Male; Wounds, Nonpenetrating | 1984 |
Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives.
Topics: beta-Lactamases; Cefmetazole; Cefotaxime; Cefotiam; Cefoxitin; Ceftizoxime; Cefuroxime; Cell Membrane Permeability; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae | 1980 |
[Sensitivity to second-generation cephem agents of clinically isolated strains of bacteria in otorhinolaryngological field (author's transl)].
Topics: Bacteria; Bacterial Infections; Cefazolin; Cefmetazole; Cefotaxime; Cefotiam; Cefuroxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Otorhinolaryngologic Diseases | 1982 |
[Cephem antibiotics and alcohol metabolism: (1) Disulfiram-like reaction resulting from intravenous administration of cephem antibiotics].
Topics: Acetaldehyde; Administration, Oral; Animals; Cefamandole; Cefazolin; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Cephamycins; Disulfiram; Drug Interactions; Ethanol; Injections, Intravenous; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1982 |
[The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Topics: Bacteria; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacter; Haemophilus influenzae; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Proteus; Streptococcus pneumoniae | 1983 |
[Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefmetazole; Cefotaxime; Cefotiam; Cefoxitin; Cephalosporins; Cephamycins; Penicillin Resistance; Penicillins; Tetracyclines | 1983 |
Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. I. Effect of NaCl.
Topics: Cefamandole; Cefazolin; Cefmetazole; Cefoperazone; Cefotiam; Drug Combinations; Drug Synergism; Methicillin; Methicillin Resistance; Sodium Chloride; Staphylococcus aureus | 1995 |
Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. II. Effect of inoculum size.
Topics: Bacteriological Techniques; Cefamandole; Cefmetazole; Cefoperazone; Cefotiam; Drug Combinations; Drug Synergism; Methicillin; Methicillin Resistance; Staphylococcus aureus | 1995 |
[Enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam in combination against methicillin-susceptible and -resistant Staphylococcus aureus studied using checkerboard MIC method and disc diffusion method with discs containing both drug
Topics: Cefmetazole; Cefotiam; Diffusion; Drug Synergism; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1993 |
Effect of side chains including the N-methyl-tetrazole-thiol group of beta-lactam antibiotics on transport in cultured kidney epithelial cells LLC-PK1.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Cefmenoxime; Cefmetazole; Cefotaxime; Cefotiam; Cells, Cultured; Epithelial Cells; Kidney; LLC-PK1 Cells; Structure-Activity Relationship; Swine; Tetrazoles | 1998 |
[Immunological properties of S-1090, cefmatilen hydrochloride hydrate].
Topics: Animals; Antigens; Cefmetazole; Cefotiam; Cephalosporins; Cephalothin; Coombs Test; Cross Reactions; Drug Hypersensitivity; Female; Guinea Pigs; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Passive Cutaneous Anaphylaxis; Penicillin G | 2001 |
[Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Cefmetazole; Cefotiam; Coagulase; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fosfomycin; Methicillin; Piperacillin; Staphylococcus; Staphylococcus aureus | 2003 |
[Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefazolin; Cefmetazole; Cefoperazone; Cefotiam; Drug Resistance, Bacterial; Humans; Japan; Sulbactam; Time Factors | 2003 |
The significance of the intraoperative repeated dosing of antimicrobials for preventing surgical wound infection in colorectal surgery.
Topics: Aged; Antibiotic Prophylaxis; Cefazolin; Cefmetazole; Cefotiam; Cefozopran; Cephalosporins; Colorectal Neoplasms; Female; Humans; Intraoperative Care; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Surgical Wound Infection | 2005 |
[Fundamental study on the selection of antimicrobial prophylactic agents in abdominal surgery].
Topics: Antibiotic Prophylaxis; Bacteria; Bacterial Infections; Cefazolin; Cefmetazole; Cefotiam; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Humans; Postoperative Complications | 2007 |
The dynamic observation of plasma concentration of antimicrobial agents during balanced ultrafiltration in vitro.
Topics: Anti-Infective Agents; Cefmetazole; Cefotiam; Equipment Design; Extracorporeal Circulation; Hemodynamics; Humans; Ultrafiltration | 2014 |
Efficacy of fosfomycin in the prevention of postoperative infection following transurethral resection of bladder tumor during periods of limited cefazolin, cefotiam, and cefmetazole supply.
Topics: Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cefotiam; Fosfomycin; Humans; Urinary Bladder Neoplasms | 2021 |